- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma, Refractory in New Zealand
Total 2625 results
-
University of NebraskaRecruiting
-
ReCode TherapeuticsRecruitingPrimary Ciliary DyskinesiaUnited Kingdom, United States, Australia, New Zealand
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
SkylineDxMedex15Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
Hackensack Meridian HealthCompletedMultiple Myeloma | Auto Stem Cell TransplantUnited States
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
AbbottBristol-Myers SquibbTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Small Intestine Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
University of California, San FranciscoTerminatedMultiple Myeloma | Patient ParticipationUnited States
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
GPCR Therapeutics, Inc.Recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Beth... and other collaboratorsCompleted
-
Incyte CorporationCompleted
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
Seagen Inc.TerminatedMultiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
University of Texas Southwestern Medical CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
CelgeneCompleted
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedMultiple MyelomaUnited States
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
AbbVieCompletedCancer | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Non-Small Cell Lung Cancer | Prostate Cancer | Non-Hodgkins Lymphoma | Acute Myeloid Leukemia (AML)United States
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
Icahn School of Medicine at Mount SinaiRecruiting
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of Alabama at BirminghamAmgenCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Lung Cancer | Prostate Cancer | Multiple Myeloma and Plasma Cell NeoplasmUnited States